ArmaGen, Inc.

JCR Pharmaceuticals Co., Ltd. , headquartered in Ashiya, Hyōgo Prefecture, holds claim to several “firsts” in Japan. In 2010, the company launched Japan’s first biosimilar product (Epoetin alfa BS inj

The progression of investigational products through a series of increasingly sophisticated and targeted clinical trials is a well-tried and tested route for the development of new medicines for commer

Shire PLC Vice President Hartmann Wellhoefer, Head of Genetic Diseases, Medical Affairs, recently spoke with Scrip about the company's research and development pipeline in lysosomal disorders and

The WORLD Symposium from Feb. 13 to 16 in San Diego brought together academic researchers and biopharmaceutical companies to share emerging research in lysosomal diseases, including next-generation en